View Item 

Show simple item record

Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in Children
dc.contributor.authorChang, Joyce C.
dc.contributor.authorYoung, Cameron C.
dc.contributor.authorMuscal, Eyal
dc.contributor.authorSexson Tejtel, Sara K.
dc.contributor.authorNewhams, Margaret M.
dc.contributor.authorKucukak, Suden
dc.contributor.authorCrandall, Hillary
dc.contributor.authorMaddux, Aline B.
dc.contributor.authorRowan, Courtney M.
dc.contributor.authorHalasa, Natasha B.
dc.contributor.authorHarvey, Helen A.
dc.contributor.authorHobbs, Charlotte V.
dc.contributor.authorHall, Mark W.
dc.contributor.authorKong, Michele
dc.contributor.authorAguiar, Cassyanne L.
dc.contributor.authorSchuster, Jennifer E.
dc.contributor.authorFitzgerald, Julie C.
dc.contributor.authorSingh, Aalok R.
dc.contributor.authorWellnitz, Kari
dc.contributor.authorNofziger, Ryan A.
dc.contributor.authorCvijanovich, Natalie Z.
dc.contributor.authorMack, Elizabeth H.
dc.contributor.authorSchwarz, Adam J.
dc.contributor.authorHeidemann, Sabrina M.
dc.contributor.authorNewburger, Jane W.
dc.contributor.authorZambrano, Laura D.
dc.contributor.authorCampbell, Angela P.
dc.contributor.authorPatel, Manish M.
dc.contributor.authorRandolph, Adrienne G.
dc.contributor.authorSon, Mary Beth F.
dc.contributor.authorKong, Michele
dc.date.accessioned2023-08-01T18:28:28Z
dc.date.available2024-09-01 14:28:26en
dc.date.available2023-08-01T18:28:28Z
dc.date.issued2023-08
dc.identifier.citationChang, Joyce C.; Young, Cameron C.; Muscal, Eyal; Sexson Tejtel, Sara K.; Newhams, Margaret M.; Kucukak, Suden; Crandall, Hillary; Maddux, Aline B.; Rowan, Courtney M.; Halasa, Natasha B.; Harvey, Helen A.; Hobbs, Charlotte V.; Hall, Mark W.; Kong, Michele; Aguiar, Cassyanne L.; Schuster, Jennifer E.; Fitzgerald, Julie C.; Singh, Aalok R.; Wellnitz, Kari; Nofziger, Ryan A.; Cvijanovich, Natalie Z.; Mack, Elizabeth H.; Schwarz, Adam J.; Heidemann, Sabrina M.; Newburger, Jane W.; Zambrano, Laura D.; Campbell, Angela P.; Patel, Manish M.; Randolph, Adrienne G.; Son, Mary Beth F.; Kong, Michele (2023). "Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in Children." Arthritis & Rheumatology 75(8): 1466-1476.
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.urihttps://hdl.handle.net/2027.42/177400
dc.publisherWiley Periodicals, Inc.
dc.titleVariation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in Children
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelRheumatology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/177400/1/art42495_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/177400/2/art42495-sup-0001-Disclosureform.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/177400/3/art42495.pdf
dc.identifier.doi10.1002/art.42495
dc.identifier.sourceArthritis & Rheumatology
dc.identifier.citedreferenceZhu YP, Shamie I, Lee JC, et al. Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C. J Clin Invest 2021; 131: e147076.
dc.identifier.citedreferenceBelhadjer Z, Auriau J, Méot M, et al. Addition of corticosteroids to immunoglobulins is associated with recovery of cardiac function in multi-inflammatory syndrome in children. Circulation 2020; 142: 2282 – 4.
dc.identifier.citedreferenceFeldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 2020; 383: 334 – 46.
dc.identifier.citedreferenceSon MBF, Murray N, Friedman K, et al. Multisystem inflammatory syndrome in children—initial therapy and outcomes. N Engl J Med 2021; 385: 23 – 34.
dc.identifier.citedreferenceKaneko N, Kurata M, Yamamoto T, et al. The role of interleukin-1 in general pathology [review]. Inflamm Regen 2019; 39: 12.
dc.identifier.citedreferencePaolera SD, Valencic E, Piscianz E, et al. Case report: use of anakinra in multisystem inflammatory syndrome during COVID-19 pandemic. Front Pediatr 2021; 8: 624248.
dc.identifier.citedreferenceBelhadjer Z, Méot M, Bajolle F, et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS–CoV-2 pandemic. Circulation 2020; 142: 429 – 36.
dc.identifier.citedreferenceLee PY, Day-Lewis M, Henderson LA, et al. Distinct clinical and immunological features of SARS–CoV-2–induced multisystem inflammatory syndrome in children. J Clin Invest 2020; 130: 5942 – 50.
dc.identifier.citedreferenceMiller J, Cantor A, Zachariah P, et al. Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children that is related to coronavirus disease 2019: a single center experience of 44 cases. Gastroenterology 2020; 159: 1571 – 4.
dc.identifier.citedreferenceMastrolia MV, Marrani E, Calabri GB, et al. Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment [letter]. Crit Care 2021; 25: 131.
dc.identifier.citedreferenceMastrolia MV, Marrani E, Maccora I, et al. The role of anti-IL-1 treatment in MIS-C patients [editorial]. Expert Opin Biol Ther 2022; 22: 1 – 5.
dc.identifier.citedreferenceHenderson LA, Canna SW, Friedman KG, et al. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS–CoV-2 and hyperinflammation in pediatric COVID-19: version 3. Arthritis Rheumatol 2022; 74: e1 – 20.
dc.identifier.citedreferenceMiller AD, Zambrano LD, Yousaf AR, et al. Multisystem inflammatory syndrome in children—United States, February 2020–July 2021 [published correction appears in Clin Infect Dis 2022;75:186]. Clin Infect Dis 2022; 75: e1165 – 75.
dc.identifier.citedreferenceSantos MO, Gonçalves LC, Silva PAN, et al. Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes. J Pediatr (Rio J) 2022; 98: 338 – 49.
dc.identifier.citedreferenceCenters for Disease Control and Prevention. Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). CDC Health Alert Network HAN00432. May 14, 2020. Accessed April 26, 2023. URL: https://emergency.cdc.gov/han/2020/han00432.asp.
dc.identifier.citedreferenceFeldstein LR, Tenforde MW, Friedman KG et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA 2021; 325: 1074 – 87.
dc.identifier.citedreferenceMatics TJ, Sanchez-Pinto LN. Adaptation and validation of a pediatric sequential organ failure assessment score and evaluation of the Sepsis-3 definitions in critically ill children. JAMA Pediatr 2017; 171: e172352.
dc.identifier.citedreferenceRavelli A, Minoia F, Davì S, et al. 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation collaborative initiative. Arthritis Rheumatol 2016; 68: 566 – 76.
dc.identifier.citedreferenceAbrams JY, Oster ME, Godfred-Cato SE, et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Health 2021; 5: 323 – 31.
dc.identifier.citedreferenceBrookhart MA, Schneeweiss S, Rothman KJ, et al. Variable selection for propensity score models. Am J Epidemiol 2006; 163: 1149 – 56.
dc.identifier.citedreferenceCrump RK, Hotz VJ, Imbens GW, et al. Dealing with limited overlap in estimation of average treatment effects. Biometrika 2009; 96: 187 – 99.
dc.identifier.citedreferenceXu S, Ross C, Raebel MA, et al. Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health 2010; 13: 273 – 7.
dc.identifier.citedreferenceCole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol 2008; 168: 656 – 64.
dc.identifier.citedreferenceNguyen TL, Collins GS, Spence J, et al. Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance. BMC Med Res Methodol 2017; 17: 78.
dc.identifier.citedreferenceBrisca G, Consolaro A, Caorsi R, et al. Timely recognition and early multi-step antinflammatory therapy may prevent ICU admission of patients with MIS-C: proposal for a severity score. Front Pediatr 2021; 9: 783745.
dc.identifier.citedreferenceConsiglio CR, Cotugno N, Sardh F, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell 2020; 183: 968 – 81.
dc.identifier.citedreferencePfeifer J, Thurner B, Kessel C, et al. Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study. Lancet Rheumatol 2022; 4: e329 – 37.
dc.identifier.citedreferenceThurner L, Kessel C, Fadle N, et al. IL-1RA antibodies in myocarditis after SARS-CoV-2 vaccination. N Engl J Med 2022:NEJMc2205667.
dc.identifier.citedreferenceWhittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020; 324: 259 – 69.
dc.identifier.citedreferenceCapone CA, Subramony A, Sweberg T, et al. Characteristics, cardiac involvement, and outcomes of multisystem inflammatory syndrome of childhood associated with severe acute respiratory syndrome coronavirus 2 infection. J Pediatr 2020; 224: 141 – 5.
dc.identifier.citedreferenceKoné-Paut I, Tellier S, Belot A, et al. Phase II open label study of anakinra in intravenous immunoglobulin–resistant Kawasaki disease. Arthritis Rheumatol 2021; 73: 151 – 61.
dc.identifier.citedreferenceCole LD, Osborne CM, Silveira LJ, et al. IVIG compared to IVIG plus infliximab in multisystem inflammatory syndrome in children. Pediatrics 2021: e2021052702.
dc.identifier.citedreferenceJain PN, Acosta S, Annapragada A, et al. Comparison of laboratory and hemodynamic time series data across original, alpha, and delta variants in patients with multisystem inflammatory syndrome in children. Pediatr Crit Care Med 2022; 23: e372 – 81.
dc.identifier.citedreferenceStierman B, Abrams JY, Godfred-Cato SE, et al. Racial and ethnic disparities in multisystem inflammatory syndrome in children in the United States, March 2020 to February 2021. Pediatr Infect Dis J 2021; 40: e400 – 6.
dc.identifier.citedreferenceLee EH, Kepler KL, Geevarughese A, et al. Race/ethnicity among children with COVID-19–associated multisystem inflammatory syndrome. JAMA Netw Open 2020; 3: e2030280.
dc.identifier.citedreferenceSavorgnan F, Acosta S, Alali A, et al. Social and demographic disparities in the severity of multisystem inflammatory syndrome in children [review]. Pediatr Infect Dis J 2022; 41: e256 – 8.
dc.identifier.citedreferenceSon MBF, Berbert L, Young C, et al. Postdischarge glucocorticoid use and clinical outcomes of multisystem inflammatory syndrome in children. JAMA Netw Open 2022; 5: e2241622.
dc.identifier.citedreferenceZachariah P. Severity predictors in pediatric SARS-CoV-2 and MIS-C. J Pediatr 2021; 232: 307 – 10.
dc.identifier.citedreferenceHarwood R, Allin B, Jones CE, et al. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process [published correction appears in Lancet Child Adolesc Health 2021;5:e5]. Lancet Child Adolesc Health 2021; 5: 133 – 41.
dc.identifier.citedreferenceHernán MA. Causal analyses of existing databases: no power calculations required. J Clin Epidemiol 2022; 144: 203 – 5.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
art42495_am.pdf
Size:
1.252MB
Format:
PDF
View/Open
Name:
art42495-sup-0001-Disclosurefo ...
Size:
2.947MB
Format:
PDF
View/Open
Name:
art42495.pdf
Size:
733.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.